Blood
Medicines for Essential thrombocythaemia
A blood condition where the bone marrow makes too many platelets, which can raise the risk of clots or bleeding — usually slow-growing and manageable, often for many years.
Education and reference only. This explains which medicines are used and why, in plain language — it deliberately contains no doses and is not a substitute for advice from your doctor or pharmacist. Always discuss your own treatment with a qualified clinician, and check the BNF and the product labelling for prescribing detail.
Quick answer
What is Essential thrombocythaemia?
Essential thrombocythaemia (ET) is a type of blood condition (one of a group called myeloproliferative neoplasms) in which the bone marrow produces too many platelets — the blood cells involved in clotting. Unlike a reactive high platelet count (which is a temporary response to another condition), in ET the overproduction comes from a change within the bone marrow cells themselves, and the platelet count is persistently raised.
- How it is treated: Essential thrombocythaemia is managed by a haematologist, and treatment is tailored to the individual's risk of clots or bleeding, based on factors such as age, symptoms, blood counts, whether there has been a previous clot, and specific test results.
- Self-care: Managing general cardiovascular risk factors — not smoking, controlling blood pressure, cholesterol and weight, and staying active — helps reduce clot risk.
- When to seek help: A persistently high platelet count is assessed by a doctor, often with referral to a haematologist.
What it is
Essential thrombocythaemia (ET) is a type of blood condition (one of a group called myeloproliferative neoplasms) in which the bone marrow produces too many platelets — the blood cells involved in clotting. Unlike a reactive high platelet count (which is a temporary response to another condition), in ET the overproduction comes from a change within the bone marrow cells themselves, and the platelet count is persistently raised. Many people with ET have no symptoms and are diagnosed after a routine blood test shows a high platelet count. When symptoms do occur, they can include headaches, dizziness, visual disturbances, and tingling or burning in the hands and feet, and the main concern is that having too many platelets can increase the risk of blood clots (which can cause problems such as a stroke or clots in the legs or lungs) and, paradoxically, sometimes an increased risk of bleeding when the count is very high. ET is usually a slow-growing (chronic) condition, and many people live with it for many years with a normal or near-normal life expectancy, though it needs monitoring and, often, treatment to reduce the risks. A small proportion can, over a long time, change into other blood conditions.
How it is treated
Essential thrombocythaemia is managed by a haematologist, and treatment is tailored to the individual's risk of clots or bleeding, based on factors such as age, symptoms, blood counts, whether there has been a previous clot, and specific test results. The aims are to reduce the risk of clots and bleeding and to control symptoms. For people at lower risk, treatment may simply involve low-dose aspirin (to reduce clot risk) and managing other cardiovascular risk factors, with regular monitoring of the blood count. For those at higher risk, medicines that reduce platelet production are used to lower the platelet count, alongside aspirin, to reduce the risk further. Controlling general cardiovascular risk factors (such as blood pressure, not smoking, and managing cholesterol and weight) is important, as these add to clot risk. Because ET is usually chronic, ongoing monitoring and follow-up track the condition and adjust treatment. The reassuring message is that essential thrombocythaemia is usually a manageable, slow-growing condition — many people live with it for many years with a good quality of life — and treatment effectively reduces the risks of clots and bleeding.
For this condition, these medicines
Medicine classes used for Essential thrombocythaemia
Each links to a full, dose-free guide — what it is, how it works, who can and cannot use it, side effects, interactions and FAQs.
Beyond medication
Lifestyle and self-care
Managing general cardiovascular risk factors — not smoking, controlling blood pressure, cholesterol and weight, and staying active — helps reduce clot risk. Taking prescribed treatment (such as aspirin and, if needed, platelet-lowering medicines) and attending regular monitoring are important.
When to get help
When to see a doctor
A persistently high platelet count is assessed by a doctor, often with referral to a haematologist. If you have essential thrombocythaemia, attend monitoring and seek urgent care for symptoms of a clot (such as stroke symptoms, or a painful, swollen leg or breathlessness) or unusual bleeding.
Not sure how urgent it is? It is always OK to call NHS 111 for advice, day or night.
Answers
Essential thrombocythaemia: frequently asked questions
What is essential thrombocythaemia?
It is a blood condition where the bone marrow makes too many platelets due to a change within the marrow cells, so the platelet count is persistently raised. This can increase the risk of blood clots (and sometimes bleeding). It is usually slow-growing and manageable.
Is essential thrombocythaemia serious?
It is usually a chronic, manageable condition, and many people live with it for many years with a normal or near-normal life expectancy. It needs monitoring and often treatment (such as aspirin and platelet-lowering medicines) to reduce the risk of clots and bleeding.
Sources
Where this is drawn from
- NHS — Essential thrombocythaemia
- British Society for Haematology guidance
Related conditions
Browse by body system
Building a patient-information or formulary resource?
We create evidence-led, dose-free clinical references and decision aids for teams.